Pinned Tweet
Clinical & Research Fellowship Available! 2 year funded fellowship focused in autoimmune liver disease with @AutoImmuneLiver @DrAliyaMD at #TCLD @UHN. Applications welcome! DM for details! @PSCPartners @PSCPartnersCa @AASLDtweets @EASLedu @ontario_gastros @CASLupdates @hepatoMD
Aliya Gulamhusein retweeted
Researchers at Mayo Clinic studied early outcomes of a remote patient monitoring program for patients with decompensated cirrhosis. Results showed high satisfaction and may potentially lead to reduced hospital readmissions and decreased morbidity: bit.ly/3A51lQS
Aliya Gulamhusein retweeted
Another accredited SCOPE Rounds session is back next week with @DrAliyaMD! Join us Tuesday, June 18 for her talk on "PBC and PSC: How I Manage These in 2024".
Register now! us02web.zoom.us/webinar/regi…
@guthealthmd
@marshllj
@vipuljairath
@hepatoMD
@jmosko29
Aliya Gulamhusein retweeted
The authors in today’s #readoftheweek📚 examined the clinical course and pattern of AILD from childhood through to adulthood.
Read here this🔓 #openaccess @JHEP_Reports article: bit.ly/4957tot
🙏 @AutoImmuneLiver et al.
#LiverTwitter
Aliya Gulamhusein retweeted
AASLD guidance on IR therapies for variceal hemorrhage.
Why specific guidance in addition to PH guidelines (soon to be published)?
→ last update TIPS guidelines 2010
→ increased use of RTO, but indications and choice between TIPS and RTO difficult bit.ly/3reqEeZ
Aliya Gulamhusein retweeted
Afsana, a new nursing graduate and #transplant recipient shares her living donor #liver transplant journey raising awareness for organ donation and transplantation via @globalnewsto
globalnews.ca/video/rd/aa0a2…
#livingdonation @UHN @TrilliumGift
Aliya Gulamhusein retweeted
Florence Wong presenting our pivotal trial experience across North America for the #alfapump in #cirrhosis @EASLedu @EASLnews #EASLCongress
Aliya Gulamhusein retweeted
I can personally vouch that being an autoimmune liver disease fellow here is a fantastic experience in Toronto with peers @InbalHouri & teachers like @AutoImmuneLiver @DrAliyaMD, along with our neighbouring experts @UHNTransplant
This Post is from an account that no longer exists. Learn more
Aliya Gulamhusein retweeted
What patients with primary sclerosing cholangitis need - according to the patients themselves
1️⃣symptom relief
2️⃣updated prognosis
3️⃣guidance on nutrition, supplements
pubmed.ncbi.nlm.nih.gov/3731…
@F8Martine in @LiverInt #LiverTwitter
Wonderful day discussing PBC at National AILD symposium @PBC_Canada @AutoImmuneLiver @InbalHouri with fantastic discussion of symptoms by the one and only @DrCynthiaLevy. More to come tomorrow!
Aliya Gulamhusein retweeted
Meet @UHN’s Dr. Eran Shlomovitz, the lone minimally invasive #surgeon and interventional radiologist in Canada!
With his unique expertise in both fields, Dr. Shlomovitz uses his precision to save #patients from painful surgeries ➜ bit.ly/3Mlklyq
@UHN_Surgery
Aliya Gulamhusein retweeted
Don't miss the original live endoscopy course. Still the best! March 29-31 in Toronto. @jmosko29 @CTeshima @ontario_gastros @CanGastroAssn @AGA_Gastro @ASGEendoscopy @AmCollegeGastro @ScopeRounds
eventbrite.com/e/34th-intern…
Aliya Gulamhusein retweeted
Another day, another renowned expert speaking on a very important topic @UofTGastroHep. Dr Christopher Rose, @CASLupdates visiting professor, speaking about the science of hepatic encephalopathy. Full house here. #livertwitter
Aliya Gulamhusein retweeted
After an extremely challenging last few weeks, it is with mixed emotions that we announce the return of our course. As in years past, we will have experts from all over the world teaching endoscopy, two full days of live endoscopy and a new hands-on course. @GaryMayEndo @CTeshima
Join us March 29-31, 2023 for the 34th International Course on Therapeutic Endoscopy!
Watch live procedures conducted by international experts by a wide variety of endoscopic techniques.
Register now: eventbrite.com/e/34th-intern…
#GItwitter #MedEd
Aliya Gulamhusein retweeted
Congrats to @MacparlandSonya @UHN who, as part of an international team of researchers, received @ChanZuckerberg funding to study #PrimarySclerosingCholangitis using single-cell biology methods. Her research will help to identify cellular targets to treat this rare liver disease.
Aliya Gulamhusein retweeted
We are devastated at @UnityHealthTO @SMH_GI with the news of the passing of our beloved friend and colleague Dr. Paul Kortan this past weekend.
nationalpost.remembering.ca/…
#gitwitter #medtwitter #Toronto
@RobertBechara @GaryMayEndo @jmosko29 @CTeshima @laura_targownik @hepatoMD
Aliya Gulamhusein retweeted
Yup. This certainly captures the essence of how we are feeling.
@globeandmail theglobeandmail.com/canada/a…
Aliya Gulamhusein retweeted
Great learning from Dr. Gulamhusein @DrAliyaMD reminding us that Tylenol, Tylenol and Tylenol 💊 is on the ddx for acute liver failure and about the importance of steroids in AIH prior to the onset of encephalopathy.
#OAG22
Aliya Gulamhusein retweeted
Advice on research by clinicians by my mentor
1️⃣ Establish deep clinical expertise
2️⃣ Ask crucial questions
3️⃣ Seek the right mentor/collaborator
4️⃣ Be creative in finding time
5️⃣ Commit and never give up
Reward🏆: Career satisfaction and low burn-out‼️
gi-org.lt.acemlnb.com/Prod/l…
Aliya Gulamhusein retweeted
Replying to @DrAliyaMD @AASLDtweets
Would be hard to believe anyone has as large a cohort globally as @DrAliyaMD !
Aliya Gulamhusein retweeted
Tour de force on cholestatic liver disease from @AutoImmuneLiver
His top 5s for PSC/PBC care and an overview of a promising clinical pipeline #TLM22






































